Bio-Techne Corporation (NASDAQ:TECH) shareholders voted on September 23 to approve the company’s acquisition by Merck KGaA of Darmstadt, Germany. The German group is paying $73 a share in cash, ...
StockStory.org on MSN
2 cash-producing stocks worth investigating and 1 we brush off
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, ...
StockStory.org on MSN
3 reasons to sell TECH and 1 stock to buy instead
Bio-Techne has had an impressive run over the past six months as its shares have beaten the S&P 500 by 21.5%. The stock now ...
Detailed price information for Bio-Techne Corp (TECH-Q) from The Globe and Mail including charting and trades.
Bio-Techne, a Minneapolis-based provider of life sciences tools, reagents, and diagnostic products, has announced that its shareholders have approved the company's proposed acquisition by Merck KGaA, ...
Bio-Techne Corporation (NASDAQ: TECH) ("Bio-Techne"), a global provider of life science tools, reagents and diagnostic products, announced that Bio-Techne shareholders voted to approve and adopt the ...
View Bio-Techne Corporation TECH stock quote prices, financial information, real-time forecasts, and company news from CNN.
Detailed price information for Bio-Techne Corp (TECH-Q) from The Globe and Mail including charting and trades.
Develops and manufactures life science reagents, analytical instruments, and diagnostic products, including proteins, antibodies, assays, and molecular diagnostic kits Generates revenue through the ...
A German company that provides products and services that accelerate drug development and manufacturing is set to acquire the Minneapolis-based group Bio-Techne, according to a news release posted ...
Bio-Techne Corporation, a global provider of life science tools, reagents and diagnostic products, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results